These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38383521)

  • 61. Diastolic shock index and clinical outcomes in patients with septic shock.
    Ospina-Tascón GA; Teboul JL; Hernandez G; Alvarez I; Sánchez-Ortiz AI; Calderón-Tapia LE; Manzano-Nunez R; Quiñones E; Madriñan-Navia HJ; Ruiz JE; Aldana JL; Bakker J
    Ann Intensive Care; 2020 Apr; 10(1):41. PubMed ID: 32296976
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants.
    Tourneux P; Rakza T; Abazine A; Krim G; Storme L
    Acta Paediatr; 2008 Feb; 97(2):177-80. PubMed ID: 18177443
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study.
    Subramanian S; Yilmaz M; Rehman A; Hubmayr RD; Afessa B; Gajic O
    Intensive Care Med; 2008 Jan; 34(1):157-62. PubMed ID: 17924093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.
    Ham KR; Boldt DW; McCurdy MT; Busse LW; Favory R; Gong MN; Khanna AK; Chock SN; Zeng F; Chawla LS; Tidmarsh GF; Ostermann M
    Ann Intensive Care; 2019 Jun; 9(1):63. PubMed ID: 31161442
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.
    Friesecke S; Stecher SS; Gross S; Felix SB; Nierhaus A
    J Artif Organs; 2017 Sep; 20(3):252-259. PubMed ID: 28589286
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is the Sympathetic System Detrimental in the Setting of Septic Shock, with Antihypertensive Agents as a Counterintuitive Approach? A Clinical Proposition.
    Petitjeans F; Geloen A; Pichot C; Leroy S; Ghignone M; Quintin L
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640590
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of fixed-dose hydrocortisone on vasopressor dose and mean arterial pressure in obese and nonobese patients with septic shock.
    Lenney M; Kopp B; Erstad B
    Am J Health Syst Pharm; 2022 Aug; 79(Suppl 3):S94-S99. PubMed ID: 35670445
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Septic shock resuscitation in the first hour.
    Simpson N; Lamontagne F; Shankar-Hari M
    Curr Opin Crit Care; 2017 Dec; 23(6):561-566. PubMed ID: 29023316
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.
    Leisman DE; Mastroianni F; Fisler G; Shah S; Hasan Z; Narasimhan M; Taylor MD; Deutschman CS
    Crit Care Explor; 2020 Oct; 2(10):e0230. PubMed ID: 33063034
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review.
    Zhou HX; Yang CF; Wang HY; Teng Y; He HY
    World J Crit Care Med; 2023 Sep; 12(4):204-216. PubMed ID: 37745258
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.
    Senatore F; Jagadeesh G; Rose M; Pillai VC; Hariharan S; Liu Q; McDowell TY; Sapru MK; Southworth MR; Stockbridge N
    Am J Cardiovasc Drugs; 2019 Feb; 19(1):11-20. PubMed ID: 30144016
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognosis of patients excluded by the definition of septic shock based on their lactate levels after initial fluid resuscitation: a prospective multi-center observational study.
    Ko BS; Kim K; Choi SH; Kang GH; Shin TG; Jo YH; Ryoo SM; Beom JH; Kwon WY; Han KS; Choi HS; Chung SP; Suh GJ; Lim TH; Kim WY;
    Crit Care; 2018 Feb; 22(1):47. PubMed ID: 29475445
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock.
    Leisman DE; Handisides DR; Chawla LS; Albertson TE; Busse LW; Boldt DW; Deane AM; Gong MN; Ham KR; Khanna AK; Ostermann M; McCurdy MT; Thompson BT; Tumlin JS; Adams CD; Hodges TN; Bellomo R
    Ann Intensive Care; 2023 Dec; 13(1):128. PubMed ID: 38103056
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of vasopressin in current anesthetic practice.
    Park KS; Yoo KY
    Korean J Anesthesiol; 2017 Jun; 70(3):245-257. PubMed ID: 28580075
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multimodal strategy to counteract vasodilation in septic shock.
    Leone M; Einav S; Antonucci E; Depret F; Lakbar I; Martin-Loeches I; Wieruszewski PM; Myatra SN; Khanna AK
    Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101193. PubMed ID: 36621622
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
    Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
    Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock.
    Garcia B; Su F; Dewachter L; Favory R; Khaldi A; Moiroux-Sahraoui A; Annoni F; Vasques-Nóvoa F; Rocha-Oliveira E; Roncon-Albuquerque R; Hubesch G; Njimi H; Vincent JL; Taccone FS; Creteur J; Herpain A
    Crit Care; 2022 Sep; 26(1):281. PubMed ID: 36117167
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evidence for a personalized early start of norepinephrine in septic shock.
    Monnet X; Lai C; Ospina-Tascon G; De Backer D
    Crit Care; 2023 Aug; 27(1):322. PubMed ID: 37608327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.